- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Melanoma, Metastatic
Total 15361 results
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital HeidelbergCompleted
-
Hoag Memorial Hospital PresbyterianCompletedMetastatic MelanomaUnited States
-
Eisai Inc.Completed
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
Duke UniversityTerminatedMetastatic MelanomaUnited States
-
University of Massachusetts, WorcesterCompleted
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
California Pacific Medical Center Research InstituteCompletedMetastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Pain TherapeuticsCompleted
-
Peking UniversityNovartisCompletedMetastatic MelanomaChina
-
Charite University, Berlin, GermanyUnknown
-
University of TurkuCompletedMetastatic MelanomaFinland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
Sheba Medical CenterRecruitingMalignant Melanoma Stage IVIsrael
-
Baylor Research InstituteCompletedMalignant Melanoma Stage IVUnited States
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Pierre Fabre MedicamentCompletedMelanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLCChina
-
Institut Jean-GodinotUniversité de Reims Champagne-ArdenneNot yet recruiting
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)RecruitingMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States
-
Centre Hospitalier Universitaire de NiceCompletedMetastatic MelanomaFrance
-
Novartis PharmaceuticalsCompleted
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedMetastatic MelanomaFrance
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); University of Southern California; University... and other collaboratorsCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawn
-
Threshold PharmaceuticalsTerminatedMetastatic MelanomaUnited States, Canada
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)Completed
-
VicalCompletedMetastatic MelanomaUnited States
-
Hadassah Medical OrganizationUnknown
-
Western Regional Medical CenterTerminated
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLCUnknownMetastatic MelanomaNetherlands
-
Hospices Civils de LyonUnknown
-
Altor BioScienceNational Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Gemin XTerminatedMetastatic MelanomaUnited States
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic MelanomaUnited States
-
SCRI Development Innovations, LLCNovartisCompletedMetastatic MelanomaUnited States
-
Medical University of ViennaTerminated